Home

in afara de asta Cel mai bun deal cma uk order generic price increases competition a atrage ruptură extinde

Pfizer epilepsy drug prices were 'unfairly high,' UK review finds | Reuters
Pfizer epilepsy drug prices were 'unfairly high,' UK review finds | Reuters

UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug | BioSpace
UK Watchdog Group Accuses Pfizer, Flynn Pharma of Price Gouging on Epilepsy Drug | BioSpace

U.K. authorities say Actavis broke competition law with 'excessive and unfair prices' on a generic | Fierce Pharma
U.K. authorities say Actavis broke competition law with 'excessive and unfair prices' on a generic | Fierce Pharma

CMA fines Advanz over 'excessive and unfair' pricing of thyroid drug - PharmaTimes
CMA fines Advanz over 'excessive and unfair' pricing of thyroid drug - PharmaTimes

Setback for CMA in £90m appeal case against big pharma :: C+D
Setback for CMA in £90m appeal case against big pharma :: C+D

Pfizer fined $106M for 2600% price hike on epilepsy drug
Pfizer fined $106M for 2600% price hike on epilepsy drug

Pricing of oral generic cancer medicines in 25 European countries; findings and implications - GaBI Journal
Pricing of oral generic cancer medicines in 25 European countries; findings and implications - GaBI Journal

Sign this petition to help bring down generic drug prices | Addison's Disease Self-Help Group
Sign this petition to help bring down generic drug prices | Addison's Disease Self-Help Group

Competition watchdog fines pharma firm over pricing of crucial thyroid drug | The Independent
Competition watchdog fines pharma firm over pricing of crucial thyroid drug | The Independent

How can competition authorities tackle price rises in a crisis? - Economics Observatory
How can competition authorities tackle price rises in a crisis? - Economics Observatory

UK's CMA Issues Fines Over Fludrocortisone :: Medtech Insight
UK's CMA Issues Fines Over Fludrocortisone :: Medtech Insight

Pfizer fined $106M for 2600% price hike on epilepsy drug
Pfizer fined $106M for 2600% price hike on epilepsy drug

UK's Competition Watchdog Targets Four Firms Over Seven-Fold Prochlorperazine Price Hike :: Generics Bulletin
UK's Competition Watchdog Targets Four Firms Over Seven-Fold Prochlorperazine Price Hike :: Generics Bulletin

Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing :: Pink Sheet
Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing :: Pink Sheet

Four drug companies accused of illegal market sharing
Four drug companies accused of illegal market sharing

UK's CMA Issues £35m In Fines Over Prochlorperazine :: Pink Sheet
UK's CMA Issues £35m In Fines Over Prochlorperazine :: Pink Sheet

Antitrust Developments in the Pharma Sector – Part I, Competition Law Insight
Antitrust Developments in the Pharma Sector – Part I, Competition Law Insight

Antitrust Developments in the Pharma Sector, Part II - Competition Law Insight
Antitrust Developments in the Pharma Sector, Part II - Competition Law Insight

CMA fines pharma firm over pricing of crucial thyroid drug - GOV.UK
CMA fines pharma firm over pricing of crucial thyroid drug - GOV.UK

Landmark ruling strikes down CMA decision on excessive and unfair pricing
Landmark ruling strikes down CMA decision on excessive and unfair pricing

Revealed: the generic price hikes increasing the NHS drugs bill - The Pharmaceutical Journal
Revealed: the generic price hikes increasing the NHS drugs bill - The Pharmaceutical Journal

UK Regulator Fines Pharma Companies for 10,000% Drug Price Increase | BioSpace
UK Regulator Fines Pharma Companies for 10,000% Drug Price Increase | BioSpace

PDF) The economics of potential price gouging during Covid-19 and the application to complaints received by the CMA
PDF) The economics of potential price gouging during Covid-19 and the application to complaints received by the CMA

UK competition regulator to ramp up pursuit of US tech giants | Financial Times
UK competition regulator to ramp up pursuit of US tech giants | Financial Times

Unfair Play: UK CMA Fines Pharmaceutical Companies for Excessive Prices | Cleary Antitrust Watch
Unfair Play: UK CMA Fines Pharmaceutical Companies for Excessive Prices | Cleary Antitrust Watch

UK's CMA Goes After Advanz, Morningside And Alliance On Nitrofurantoin :: Generics Bulletin
UK's CMA Goes After Advanz, Morningside And Alliance On Nitrofurantoin :: Generics Bulletin

What is the Competition and Markets Authority - and why should you care - Startups.co.uk
What is the Competition and Markets Authority - and why should you care - Startups.co.uk